This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Sustained-Release Bevacizumab

pSivida Corporation

Drug Names(s): sustained release bevacizumab, Tethadur

Description: pSivida is evaluating a sustained release form of Avastin (bevacizumab), using the Company's Tethadur delivery technology.

pSivida’s Tethadur utilizes a tunable nano-porous, elemental silicon-based structure to provide sustained delivery of large biologic molecules.


Sustained-Release Bevacizumab News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug